New Issue-Watson Pharmaceuticals sells $850 mln in 2 parts
Aug 18 (Reuters) - Watson Pharmaceuticals Inc (WPI.N) on
Tuesday sold $850 million of notes in two parts, said IFR, a
Thomson Reuters service.
Bank of America and Barclays were the joint active bookrunning managers for the sale and Wells Fargo was the sole passive bookrunning manager for the sale. BORROWER: WATSON PHARMACEUTICALS INC TRANCHE ONE: AMT $450 MLN COUPON 5.00 PCT MATURITY 8/15/2014 TYPE NOTES ISS PRICE 99.589 FIRST PAY 2/15/2010 MOODY'S Ba1 YIELD 5.095 PCT SETTLEMENT 8/24/2009 S&P BBB-MINUS SPREAD 262.5 BPS PAY FREQ SEMI-ANNUAL FITCH BBB-MINUS MORE THAN TREAS MAKE-WHOLE CALL 40 BPS TRANCHE TWO: AMT $400 MLN COUPON 6.125 PCT MATURITY 8/15/2019 TYPE NOTES ISS PRICE 99.796 FIRST PAY 2/15/2010 MOODY'S Ba1 YIELD 6.153 PCT SETTLEMENT 8/24/2009 S&P BBB-MINUS SPREAD 262.5 BPS PAY FREQ SEMI-ANNUAL FITCH BBB-MINUS MORE THAN TREAS MAKE-WHOLE CALL 40 BPS
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters